peptide elongation factor 2 has been researched along with Deficiency, Mental in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cotrina-Vinagre, FJ; de Aragón, AM; de Las Heras, RS; de Vries, BBA; Dinman, JD; Martínez-Azorín, F; Nabais Sá, MJ; Olson, AN; Quijada-Fraile, P; Rodríguez-García, ME; Sánchez-Calvin, MT | 1 |
| Alves, CAP; Bird, LM; Cook, EB; Guo, R; Izumi, K; Rippert, AL | 1 |
2 other study(ies) available for peptide elongation factor 2 and Deficiency, Mental
| Article | Year |
|---|---|
A novel de novo variant in CASK causes a severe neurodevelopmental disorder that masks the phenotype of a novel de novo variant in EEF2.
Topics: Humans; Intellectual Disability; Microcephaly; Mutation; Peptide Elongation Factor 2; Phenotype | 2023 |
Expansion of clinical and variant spectrum of EEF2-related neurodevelopmental disorder: Report of two additional cases.
Topics: Adult; Autism Spectrum Disorder; Child; Child, Preschool; Female; Genotype; Humans; Intellectual Disability; Language Development Disorders; Male; Neurodevelopmental Disorders; Peptide Elongation Factor 2; Phenotype | 2023 |